Predict your next investment

Tempus company logo
Corporation
HEALTHCARE | Biotechnology
tempus.com

See what CB Insights has to offer

Total Raised

$1.07B

Investors Count

10

Deal Terms

6

Tempus Funding, Tempus Valuation & Tempus Revenue

9 Fundings

Tempus's latest funding round was a Series G - II for $200M on December 10, 2020.

Tempus's valuation in May 2019 was $3,100M.

Tempus's latest post-money valuation is from December 2020.

Sign up for a free 30-day trial to see Tempus's valuations in December 2020 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/10/2020

Series G - II

$200M

$99M

$0.00B

((9.99x))

FY 1234

2

12/10/2020

Convertible Note

$99M

$0.00B

((9.99x))

FY 1234

10

3/13/2020

Series G

$99M

$0.00B

((9.99x))

FY 1234

10

5/30/2019

Series F

$99M

$3,100M

$0.00B

((9.99x))

FY 1234

10

8/29/2018

Series E

$99M

$0.00B

((9.99x))

FY 1234

10

Date

12/10/2020

12/10/2020

3/13/2020

5/30/2019

8/29/2018

Round

Series G - II

Convertible Note

Series G

Series F

Series E

Amount

$200M

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

$3,100M

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

2

10

10

10

10

Tempus Deal Terms

6 Deal Terms

Tempus's deal structure is available for 6 funding rounds, including their Series G - II from December 10, 2020.

Round

Series G - II

Series G

Series F

Series E

Series D

Funding Date

$99M

$99M

$99M

$99M

$99M

Pre-Money Valuation

$99M

$99M

$99M

$99M

$99M

Post-Money Valuation

$99M

$99M

$99M

$99M

$99M

Amount Raised

$99M

$99M

$99M

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series G - II

$99M

$99M

$99M

$99M

$99M

$99M

Series G

$99M

$99M

$99M

$99M

$99M

$99M

Series F

$99M

$99M

$99M

$99M

$99M

$99M

Series E

$99M

$99M

$99M

$99M

$99M

$99M

Series D

$99M

$99M

$99M

$99M

$99M

$99M

Tempus Investors

10 Investors

Tempus has 10 investors. T. Rowe Price invested in Tempus's Series G - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

3/21/2018

12/10/2020

5
Series D, Series E (2018), Series F (2019), Series G (2020), Series G - II (2020)

Mutual Fund

Maryland

8/29/2018

12/10/2020

4
Series E, Series F (2019), Series G (2020), Series G - II (2020)

Asset/Investment Management

United Kingdom

5/30/2019

12/10/2020

3
Series F, Series G (2020), Series G - II (2020)

Holding Company

Denmark

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Asset/Investment Management

California

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Angel Investor (Individual)

Illinois

First funding

3/21/2018

8/29/2018

5/30/2019

00/00/0000

00/00/0000

Last Funding

12/10/2020

12/10/2020

12/10/2020

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

5
Series D, Series E (2018), Series F (2019), Series G (2020), Series G - II (2020)
4
Series E, Series F (2019), Series G (2020), Series G - II (2020)
3
Series F, Series G (2020), Series G - II (2020)

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Mutual Fund

Asset/Investment Management

Holding Company

Asset/Investment Management

Angel Investor (Individual)

Location

Maryland

United Kingdom

Denmark

California

Illinois

Tempus Acquisitions

1 Acquisition

Tempus acquired 1 company. Their latest acquisition was AKESOgen on December 12, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/12/2019

Unattributed

$1.5M

Acquired

1

Date

12/12/2019

Investment Stage

Unattributed

Companies

Valuation

Total Funding

$1.5M

Note

Acquired

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.